PLAUR and Hepatic fibrosis: In MM, urokinase-type plasminogen activator receptor (uPAR) was reported to increase cancer-associated fibroblasts during disease progression, and anti-uPAR CAR T was shown to ablate the cells in vitro and in vivo and restore tissue homeostasis in mice with liver fibrosis [132].